SEC Form 424B5 filed by Healthpeak Properties Inc.

$DOC
Real Estate Investment Trusts
Real Estate
Get the next $DOC alert in real time by email
424B5 1 tm255424-8_424b5.htm 424B5 tm255424-8_424b5 - none - 1.656254s
 Filed Pursuant to Rule 424(b)(5)
 Registration No. 333-276954
PROSPECTUS SUPPLEMENT
(To Prospectus Supplement dated March 11, 2024
and Prospectus dated February 5, 2025)
[MISSING IMAGE: lg_healthpeak-bwlr.jpg]
$1,500,000,000
Healthpeak Properties, Inc.
Common Stock
This prospectus supplement is being filed to update, amend and supplement certain information in the prospectus supplement dated and filed with the Securities and Exchange Commission on March 11, 2024 (the “Original Prospectus Supplement”), as amended by the prospectus supplement dated and filed with the Securities and Exchange Commission on May 3, 2024, and the base prospectus dated February 5, 2025 (the “Prospectus”) relating to the offering of shares of our common stock, $1.00 par value per share, having an aggregate gross sales price of up to $1,500,000,000 pursuant to an “at-the-market” equity offering sales agreement, as amended from time to time, referred to in this prospectus supplement as the “sales agreement,” with each of J.P. Morgan Securities LLC, Robert W. Baird & Co. Incorporated, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC, as sales agents or as principals (the “Sales Agents”), the Forward Sellers (as defined in the Original Prospectus Supplement) and the Forward Purchasers (as defined in the Original Prospectus Supplement). As of the date of this prospectus supplement, no shares of our common stock have been offered and sold under the sales agreement. Accordingly, shares of our common stock having an aggregate offering price of up to $1,500,000,000 remain available for offer and sale pursuant to the sales agreement. This prospectus supplement is only intended to update, amend and supplement certain information in the Original Prospectus Supplement to the extent set forth in the following paragraph. You should read this prospectus supplement together with the Original Prospectus Supplement and Prospectus.
On February 6, 2025, we entered into an amendment to the sales agreement with the Sales Agents, the Forward Purchasers, the Forward Sellers, M&T Securities, Inc. (“M&T Securities”), Santander US Capital Markets LLC (“Santander”) and Banco Santander, S.A. (“Banco Santander”) to add M&T Securities as a Sales Agent, add Santander as a Sales Agent and a Forward Seller and add Banco Santander as a Forward Purchaser under the sales agreement. Accordingly, any reference to “Sales Agent” or “Sales Agents” in the Original Prospectus Supplement shall hereafter be deemed to include M&T Securities and Santander, any reference to “Forward Seller” or “Forward Sellers” in the Original Prospectus Supplement shall hereafter be deemed to include Santander and any reference to “Forward Purchaser” or “Forward Purchasers” in the Original Prospectus Supplement shall hereafter be deemed to include Banco Santander.
Investing in our common stock involves risks. See “Risk Factors” beginning on page S-4 of the Original Prospectus Supplement and page 2 of the accompanying prospectus and the risk factors described in our most recent Annual Report on Form 10-K for the year ended December 31, 2024, as well as the risk factors relating to our business contained in documents we file with the Securities and Exchange Commission, which are incorporated by reference into this prospectus supplement and the accompanying prospectus.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined that this prospectus supplement or the accompanying prospectus is accurate or complete. Any representation to the contrary is a criminal offense.
J.P. Morgan
Baird
Barclays
BNP PARIBAS
BofA Securities
BTIG
Capital One Securities
Credit Agricole CIB
Goldman Sachs &
Co. LLC
Jefferies
KeyBanc Capital Markets
M&T Securities
Mizuho
Morgan Stanley
RBC Capital Markets
Regions Securities LLC
Santander
Scotiabank
TD Securities
Truist Securities
Wells Fargo Securities
The date of this prospectus supplement is February 6, 2025

Get the next $DOC alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DOC

DatePrice TargetRatingAnalyst
1/15/2025$25.00Equal-Weight → Overweight
Morgan Stanley
10/21/2024$20.00 → $28.00Hold → Buy
Deutsche Bank
5/3/2024Neutral → Outperform
Wedbush
4/26/2024$19.00 → $21.00Neutral → Outperform
Exane BNP Paribas
4/22/2024$22.00Buy
Mizuho
4/1/2024$18.00 → $25.00Underperform → Buy
BofA Securities
3/25/2024$19.00Equal Weight
Wells Fargo
3/8/2024$21.00Outperform
RBC Capital Mkts
More analyst ratings

$DOC
Press Releases

Fastest customizable press release news feed in the world

See more
  • Land & Buildings Nominates Two Independent Candidates – Jim Hoffmann and Adam Troso – for Board of National Health Investors

    Believes That Incremental Changes Since Last Annual Meeting Are Insufficient to Address the Poor Corporate Governance and Concerning Conflicts of Interest Threatening to Prevent NHI From Reaching its Full Value Potential Highlights the Urgent Need for NHI to Have Truly Independent Directors With the Right Expertise in the Boardroom Given Ongoing Lease Renewal Negotiations With Major Tenant National Healthcare Corp (NHC) Details Concerns That NHC Lease Negotiations Will Not Reflect Market Value Given Board Member Conflicts; Lease Likely Has 75% Upside Based on Strong Coverage and Precedent Transactions and Could Boost Earnings 13% Or More Believes NHI Shares Have 50% Upside Over the Next

    $DOC
    $GHL
    $HCP
    $ING
    Real Estate Investment Trusts
    Real Estate
    Investment Bankers/Brokers/Service
    Finance
  • Healthpeak Prices Offering of $500.0 Million of 5.375% Senior Unsecured Notes due 2035

    Healthpeak Properties, Inc. ("Healthpeak") (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that its operating company, Healthpeak OP, LLC (the "operating company"), has priced a public offering of $500.0 million aggregate principal amount of 5.375% senior unsecured notes due 2035 (the "notes"). The notes will be senior unsecured obligations of the operating company and will be fully and unconditionally guaranteed, on a joint and several basis, by Healthpeak, DOC DR Holdco, LLC and DOC DR, LLC. The price to investors was 99.549% of the principal amount of the notes. The estimated net proceeds of the offering are exp

    $DOC
    Real Estate Investment Trusts
    Real Estate
  • Healthpeak Properties Reports Fourth Quarter and Year Ended 2024 Results and Increases Cash Dividend

    Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the fourth quarter and year ended December 31, 2024. FOURTH QUARTER 2024 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS Net income of $0.01 per share, Nareit FFO of $0.44 per share, FFO as Adjusted of $0.46 per share, AFFO of $0.40 per share, and Total Same-Store Portfolio Cash (Adjusted) NOI growth of 5.4% Healthpeak's Board of Directors declared a 1.7% increase in the Company's quarterly common stock cash dividend to $0.305 per share Fourth quarter new and renewal lease executions totaled 1.5 million square feet: Outpa

    $DOC
    Real Estate Investment Trusts
    Real Estate

$DOC
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$DOC
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$DOC
SEC Filings

See more

$DOC
Leadership Updates

Live Leadership Updates

See more
  • American Homes 4 Rent Set to Join S&P MidCap 400

    NEW YORK, Feb. 26, 2024 /PRNewswire/ -- American Homes 4 Rent (NYSE:AMH) will replace Physicians Realty Trust (NYSE:DOC) in the S&P MidCap 400 effective prior to the opening of trading on Friday, March 1. S&P 500 constituent Healthpeak Properties Inc. (NYSE:PEAK) is acquiring Physicians Realty Trust in a deal expected to be completed soon pending final conditions. Post-merger, Healthpeak Properties will have a symbol change from PEAK to DOC. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector March 1, 2024 S&P MidCap 400 Addition American Homes 4 Rent AMH Real E

    $AMH
    $DOC
    $PEAK
    $SPGI
    Real Estate Investment Trusts
    Real Estate
    Finance: Consumer Services
    Finance

$DOC
Financials

Live finance-specific insights

See more
  • Land & Buildings Nominates Two Independent Candidates – Jim Hoffmann and Adam Troso – for Board of National Health Investors

    Believes That Incremental Changes Since Last Annual Meeting Are Insufficient to Address the Poor Corporate Governance and Concerning Conflicts of Interest Threatening to Prevent NHI From Reaching its Full Value Potential Highlights the Urgent Need for NHI to Have Truly Independent Directors With the Right Expertise in the Boardroom Given Ongoing Lease Renewal Negotiations With Major Tenant National Healthcare Corp (NHC) Details Concerns That NHC Lease Negotiations Will Not Reflect Market Value Given Board Member Conflicts; Lease Likely Has 75% Upside Based on Strong Coverage and Precedent Transactions and Could Boost Earnings 13% Or More Believes NHI Shares Have 50% Upside Over the Next

    $DOC
    $GHL
    $HCP
    $ING
    Real Estate Investment Trusts
    Real Estate
    Investment Bankers/Brokers/Service
    Finance
  • Healthpeak Properties Reports Fourth Quarter and Year Ended 2024 Results and Increases Cash Dividend

    Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the fourth quarter and year ended December 31, 2024. FOURTH QUARTER 2024 FINANCIAL PERFORMANCE AND RECENT HIGHLIGHTS Net income of $0.01 per share, Nareit FFO of $0.44 per share, FFO as Adjusted of $0.46 per share, AFFO of $0.40 per share, and Total Same-Store Portfolio Cash (Adjusted) NOI growth of 5.4% Healthpeak's Board of Directors declared a 1.7% increase in the Company's quarterly common stock cash dividend to $0.305 per share Fourth quarter new and renewal lease executions totaled 1.5 million square feet: Outpa

    $DOC
    Real Estate Investment Trusts
    Real Estate
  • Healthpeak Properties Announces Tax Treatment of 2024 Distributions

    Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today the tax treatment of its 2024 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid to shareholders during the calendar year ended December 31, 2024: Common Stock (CUSIP # 42250P103)             Ordinary Dividends   Capital Gains     Record Date   Payment Date   Distribution Per Share   Total   Non-Qualified   Qualified   Total   Long Term   Unrecaptured Section 1250   Nond

    $DOC
    Real Estate Investment Trusts
    Real Estate

$DOC
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more